Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_assertion description "[The aims of this study were to evaluate the effect of embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone), an antagonist of XIAP, on colon cancer, with a particular focus on whether PPARgamma is required for embelin to exert its effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_assertion evidence source_evidence_literature NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_assertion SIO_000772 19458067 NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_assertion wasDerivedFrom befree-20140225 NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_assertion wasGeneratedBy ECO_0000203 NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP322061.RAIHFFX5r_AucU_lmN-sAn_CMFQ-ZsBYGsfOZ7dydX5m4130_provenance.